Patent ID: 11931398
Assignee: FERRING B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 15:
16. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition exhibits a stability such that one or more of:
(a) after being stored at 25° C. and 60% relative humidity for a period of time of at least one year, the total impurity content in the composition is less than about 1.9% w/w based on the total weight of the terlipressin;
(b) after being stored at 25° C. and 60% relative humidity for a period of time of 12 months, the total impurity content in the composition is less than about 1.9% w/w based on the total weight of the terlipressin;
(c) after being stored at 25° C. and 60% relative humidity for a period of time of 18 months, the total impurity content in the composition is less than about 1.9% w/w based on the total weight of the terlipressin;
(d) after being stored at 25° C. and 60% relative humidity for a period of time of 24 months, the total impurity content in the composition is less than about 1.9% w/w based on the total weight of the terlipressin; and
(e) after being stored at 25° C. and 60% relative humidity for a period of time of 36 months, the total impurity content in the composition is less than about 1.9% w/w based on the total weight of the terlipressin.